Bridgeway Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bridgeway Capital Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-55,686	Closed	-$184K	–	1535
2016 Q2	$184K	Sell	55,686 -37,514	-40%	-$142K	﹤0.01%	1319
2016 Q1	$331K	Buy	+93,200	New	+$480K	0.01%	1192

Other funds holding ARLZ

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

Bridgeway Capital Management's ARLZ Position: Q3 2016 in Review

Bridgeway Capital Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2016, closing a stake of 55,686 shares — an estimated $184K sold.

Bridgeway Capital Management first reported a position in ARLZ in Q1 2016 and held it in 2 quarters. The position peaked at $331K in Q1 2016. 83 funds tracked by Wall St. Rank hold ARLZ as of Q3 2016.

Bridgeway Capital Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
Bridgeway Capital Management sold 55,686 Aralez Pharmaceuticals Inc. shares in Q3 2016, an estimated $184K.
Bridgeway Capital Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 2 quarters.
Bridgeway Capital Management's Aralez Pharmaceuticals Inc. position peaked at $331K in Q1 2016.
83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2016.

Based on Bridgeway Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.